Chagasic patients are able to respond against a viral antigen from influenza virus

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Lasso, Paola ^a   Mesa, Diana ^a   Bolaños, Natalia ^b   Cuéllar, Adriana ^a   Guzmán, Fanny ^c   Cucunuba, Zulma ^d   Rosas, Fernando ^e   Velasco, Víctor ^e   Thomas, Maria C ^f   López, Manuel C ^f   González, John M ^b   Puerta, Concepción J ^a  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b UNIVERSIDAD DE LOS ANDES   (Colombia)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^d INSTITUTO NACIONAL DE SALUD   (Colombia)

^e Fundacion Clinica Abood Shaio   (Colombia)

^f INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

CD8+ T cells; Chagas disease; Non T. cruzi microbial antigen; Nonspecific immune suppression

Indexed keywords

CHEMOKINE RECEPTOR CCR7; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; INTERLEUKIN 2; L SELECTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PERFORIN; VIRUS ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CELLULAR IMMUNODEFICIENCY; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFLUENZA VIRUS; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-2; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; ORTHOMYXOVIRIDAE; PERFORIN; T-LYMPHOCYTE SUBSETS; TRYPANOSOMA CRUZI;

EID: 84865304499     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-198     Document Type: Article

References (43)

1. WHO Chagas disease (American trypanosomiasis) fact sheet (revised in June 2010). Wkly Epidemiol Rec 2010, 85(34):334-336. WHO.
2. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010, 115(1-2):14-21.
3. Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, Castelli F, Gkrania-Klotsas E, Weld L, Lopez-Velez R, et al. Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis 2010, 10:330. 10.1186/1471-2334-10-330, 3001727, 21083874.
4. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001, 1(2):92-100. 10.1016/S1473-3099(01)00065-2, 11871482.
5. Teixeira AR, Hecht MM, Guimaro MC, Sousa AO, Nitz N. Pathogenesis of chagas' disease: parasite persistence and autoimmunity. Clin Microbiol Rev 2011, 24(3):592-630. 10.1128/CMR.00063-10, 3131057, 21734249.
6. Rassi A, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010, 375(9723):1388-1402. 10.1016/S0140-6736(10)60061-X, 20399979.
7. Higuchi Mde L, Benvenuti LA, Martins Reis M, Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003, 60(1):96-107. 10.1016/S0008-6363(03)00361-4, 14522411.
8. Martin D, Tarleton R. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol Rev 2004, 201:304-317. 10.1111/j.0105-2896.2004.00183.x, 15361249.
9. Muller U, Sobek V, Balkow S, Holscher C, Mullbacher A, Museteanu C, Mossmann H, Simon MM. Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent on the FasL/Fas pathway. Eur J Immunol 2003, 33(1):70-78. 10.1002/immu.200390009, 12594834.
10. Tarleton RL, Sun J, Zhang L, Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun 1994, 62(5):1820-1829. 186416, 8168945.
11. Albareda MC, Laucella SA, Alvarez MG, Armenti AH, Bertochi G, Tarleton RL, Postan M. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int Immunol 2006, 18(3):465-471. 10.1093/intimm/dxh387, 16431876.
12. Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 2007, 19(4):408-415. 10.1016/j.coi.2007.06.004, 17656078.
13. Leavey JK, Tarleton RL. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J Immunol 2003, 170(5):2264-2268.
14. Tzelepis F, de Alencar BC, Penido ML, Claser C, Machado AV, Bruna-Romero O, Gazzinelli RT, Rodrigues MM. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance. J Immunol 2008, 180(3):1737-1748.
15. Alvarez MG, Postan M, Weatherly DB, Albareda MC, Sidney J, Sette A, Olivera C, Armenti AH, Tarleton RL, Laucella SA. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease. PLoS Negl Trop Dis 2008, 2(9):e288. 10.1371/journal.pntd.0000288, 2565697, 18846233.
16. Diez H, Lopez MC, Del Carmen Thomas M, Guzman F, Rosas F, Velazco V, Gonzalez JM, Puerta C. Evaluation of IFN-gamma production by CD8 T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi. Parasit Immunol 2006, 28(3):101-105.
17. Fonseca SG, Moins-Teisserenc H, Clave E, Ianni B, Nunes VL, Mady C, Iwai LK, Sette A, Sidney J, Marin ML, et al. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microb Infect Institut Pasteur 2005, 7(4):688-697.
18. Garcia F, Sepulveda P, Liegeard P, Gregoire J, Hermann E, Lemonnier F, Langlade-Demoyen P, Hontebeyrie M, Lone YC. Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients. Microb Infect Institut Pasteur 2003, 5(5):351-359.
19. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, Alvarez MG, Lococo B, Barbieri G, Viotti RJ, Tarleton RL. Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 2004, 189(5):909-918. 10.1086/381682, 14976609.
20. Martin DL, Weatherly DB, Laucella SA, Cabinian MA, Crim MT, Sullivan S, Heiges M, Craven SH, Rosenberg CS, Collins MH, et al. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2006, 2(8):e77. 10.1371/journal.ppat.0020077, 1526708, 16879036.
21. Marañón C, Egui A, Carrilero B, Thomas MC, Pinazo MJ, Gascón J, Segovia M, López MC. Identification of HLA-A*02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients. Microb Infect 2011, 13(12-13):1025-1032.
22. Borges M, Da Silva AC, Sereno D, Ouaissi A. Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor. Immunology 2003, 109(1):147-155. 10.1046/j.1365-2567.2003.01637.x, 1782932, 12709028.
23. Michelin MA, Silva JS, Cunha FQ. Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp Parasitol 2005, 111(2):71-79. 10.1016/j.exppara.2005.05.001, 16009364.
24. Minoprio P, Itohara S, Heusser C, Tonegawa S, Coutinho A. Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells. Immunol Rev 1989, 112:183-207. 10.1111/j.1600-065X.1989.tb00558.x, 2514135.
25. Poncini CV, Alba Soto CD, Batalla E, Solana ME, Gonzalez Cappa SM. Trypanosoma cruzi induces regulatory dendritic cells in vitro. Infect Immun 2008, 76(6):2633-2641. 10.1128/IAI.01298-07, 2423106, 18347042.
26. Padilla AM, Simpson LJ, Tarleton RL. Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J Immunol 2009, 183(2):1245-1252. 10.4049/jimmunol.0901178, 19553540.
27. Krausa P, Brywka M, Savage D, Hui KM, Bunce M, Ngai JL, Teo DL, Ong YW, Barouch D, Allsop CE, et al. Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 1995, 45(4):223-231. 10.1111/j.1399-0039.1995.tb02444.x, 7638857.
28. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004, 78(11):5535-5545. 10.1128/JVI.78.11.5535-5545.2004, 415833, 15140950.
29. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002, 8(4):379-385. 10.1038/nm0402-379, 11927944.
30. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004, 22:745-763. 10.1146/annurev.immunol.22.012703.104702, 15032595.
31. Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998, 394(6692):482-485. 10.1038/28860, 9697771.
32. Britten CM, Janetzki S, Ben-Porat L, Clay TM, Kalos M, Maecker H, Odunsi K, Pride M, Old L, Hoos A, et al. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Canc Immunol Immunother 2009, 58(10):1701-1713.
33. Hoji A, Rinaldo CR. Human CD8+ T cells specific for influenza A virus M1 display broad expression of maturation-associated phenotypic markers and chemokine receptors. Immunology 2005, 115(2):239-245. 10.1111/j.1365-2567.2005.02135.x, 1782154, 15885130.
34. Lasso P, Mesa D, Cuellar A, Guzman F, Bolanos N, Rosas F, Velasco V, Thomas Mdel C, Lopez MC, Gonzalez JM, et al. Frequency of specific CD8+ T cells for a promiscuous epitope derived from Trypanosoma cruzi KMP-11 protein in chagasic patients. Parasite Immunol 2010, 32(7):494-502. 10.1111/j.1365-3024.2010.01206.x, 20591120.
35. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000, 192(1):63-75. 10.1084/jem.192.1.63, 1887711, 10880527.
36. Dauby N, Alonso-Vega C, Suarez E, Flores A, Hermann E, Cordova M, Tellez T, Torrico F, Truyens C, Carlier Y. Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines. PLoS Negl Trop Dis 2009, 3(12):e571. 10.1371/journal.pntd.0000571, 2796860, 20041029.
37. Bern C, Montgomery SP, Herwaldt BL, Rassi A, Marin-Neto JA, Dantas RO, Maguire JH, Acquatella H, Morillo C, Kirchhoff LV, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 2007, 298(18):2171-2181. 10.1001/jama.298.18.2171, 18000201.
38. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46(6):e1-e82. 10.1016/j.jacc.2005.08.022, 16168273.
39. Bednarek MA, Sauma SY, Gammon MC, Porter G, Tamhankar S, Williamson AR, Zweerink HJ. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J Immunol 1991, 147(12):4047-4053.
40. Chaves F, Calvo JC, Carvajal C, Rivera Z, Ramirez L, Pinto M, Trujillo M, Guzman F, Patarroyo ME. Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages. J Pept Res Offic J Am Pept Soc 2001, 58(4):307-316.
41. Parham P, Brodsky FM. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 1981, 3(4):277-299. 10.1016/0198-8859(81)90065-3, 7035415.
42. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 46(5):355-367. 10.1111/j.1399-0039.1995.tb03127.x, 8838344.
43. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007, 13(7):843-850. 10.1038/nm1592, 17558415.